| dc.contributor.author | DEWI, Taufik Muhammad | |
| dc.date.accessioned | 2020-10-29T10:23:07Z | |
| dc.date.available | 2020-10-29T10:23:07Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | APA | en_US |
| dc.identifier.issn | p-ISSN 2477-0612 | |
| dc.identifier.uri | https://scholarhub.ui.ac.id/psr/vol7/iss4/8/ | |
| dc.identifier.uri | http://hdl.handle.net/123456789/27835 | |
| dc.language.iso | en | en_US |
| dc.publisher | Faculty of Pharmacy Universitas Indonesia | en_US |
| dc.relation.ispartofseries | Pharmaceutical Sciences and Research;Vol. 7, No. 4 (2020) | |
| dc.subject | COVID-19 | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | SARS-CoV-2 SPIKE PROTEIN | en_US |
| dc.subject | DERMASEPTIN | en_US |
| dc.subject | ANTIVIRAL PEPTIDE | en_US |
| dc.subject | IN SILICO STUDY | en_US |
| dc.title | Dermaseptin-ased Antiviral Peptides to Prevent COVID-19 through In Silico Molecular Docking Studies against SARS-CoV-2 Spike Protein | en_US |
| dc.title.alternative | Dermaseptin-based antiviral peptides to prevent COVID-19 through in silico molecular docking studies against SARS-CoV-2 spike protein | en_US |
| dc.type | Article | en_US |